BE712514A - - Google Patents
Info
- Publication number
- BE712514A BE712514A BE712514DA BE712514A BE 712514 A BE712514 A BE 712514A BE 712514D A BE712514D A BE 712514DA BE 712514 A BE712514 A BE 712514A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB03252/67A GB1170807A (en) | 1967-03-21 | 1967-03-21 | Quinoxaline Derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE712514A true BE712514A (en:Method) | 1968-09-20 |
Family
ID=10019595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE712514D BE712514A (en:Method) | 1967-03-21 | 1968-03-20 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3479354A (en:Method) |
| BE (1) | BE712514A (en:Method) |
| CH (1) | CH500205A (en:Method) |
| DE (1) | DE1695302A1 (en:Method) |
| DK (1) | DK128610B (en:Method) |
| FR (2) | FR1580185A (en:Method) |
| GB (1) | GB1170807A (en:Method) |
| IE (1) | IE31965B1 (en:Method) |
| NL (1) | NL6803796A (en:Method) |
| SE (1) | SE342456B (en:Method) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4006142A (en) * | 1973-03-07 | 1977-02-01 | Pfizer Inc. | Preparation of methyl-3-(2-quinoxalinylmethylene)carbazate-N1,N4 -dioxide |
| US3926991A (en) * | 1973-03-07 | 1975-12-16 | Pfizer | Process for producing quinoxaline-di-N-oxides |
| US4803209A (en) * | 1987-08-27 | 1989-02-07 | International Minerals & Chemical Corp. | Substituted 2,3-diphenyl-1,2-dihydroquinoxalines |
-
1967
- 1967-03-21 GB GB03252/67A patent/GB1170807A/en not_active Expired
-
1968
- 1968-02-19 US US706650A patent/US3479354A/en not_active Expired - Lifetime
- 1968-02-23 IE IE219/68A patent/IE31965B1/xx unknown
- 1968-02-29 DE DE19681695302 patent/DE1695302A1/de active Pending
- 1968-03-18 NL NL6803796A patent/NL6803796A/xx unknown
- 1968-03-20 DK DK120968AA patent/DK128610B/da unknown
- 1968-03-20 SE SE3680/68A patent/SE342456B/xx unknown
- 1968-03-20 FR FR1580185D patent/FR1580185A/fr not_active Expired
- 1968-03-20 BE BE712514D patent/BE712514A/xx unknown
- 1968-03-20 CH CH413468A patent/CH500205A/de not_active IP Right Cessation
- 1968-06-19 FR FR155701A patent/FR7897M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| SE342456B (en:Method) | 1972-02-07 |
| DK128610B (da) | 1974-06-04 |
| FR1580185A (en:Method) | 1969-09-05 |
| US3479354A (en) | 1969-11-18 |
| DE1695302A1 (de) | 1971-03-18 |
| CH500205A (de) | 1970-12-15 |
| GB1170807A (en) | 1969-11-19 |
| FR7897M (en:Method) | 1970-05-04 |
| NL6803796A (en:Method) | 1968-09-23 |
| IE31965B1 (en) | 1973-03-07 |
| IE31965L (en) | 1968-09-21 |